October has been better for biotech stocks like Gilead Sciences (GILD), Amgen (AMGN) and Regeneron (REGN) following their September shellacking. JPMorgan’s Cory Kasimov and team argue that “sentiment is still tenuous” although “people feel better than they did a week ago.” They explain: Bloomberg News [Overall,] while sentiment is still tenuous, people feel better than […]
Kilde: Biotech: Sentiment Still Tenuous?
0 kommentarer